Status of Anti-Lung Cancer Drug Patents Applications in China from 2003 to 2012
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
9
Page:
221-240
Author(s):
Da-ming Chen, Kai-yun Mao, Lu Yang and Hong-bo Jiang
Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers
Journal:
Current Cancer Therapy Reviews
Volume:
9
Page:
265-277
Author(s):
Ana Paula Delgado, Pamela Brandao, Sheilin Hamid and Ramaswamy Narayanan
Cancer-associated Autoantibodies as Biomarkers for Early Detection and Prognosis is Cancer: An Update
Journal:
Current Cancer Therapy Reviews
Volume:
9
Page:
227-235
Author(s):
Irena Meistere, Zane Kalnina, Karina Silina and Aija Line
Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Journal:
Current Signal Transduction Therapy
Volume:
8
Page:
180-192
Author(s):
Bozena Kaminska, Dorota Weronika Kulesza and Kavita Ramji
Novel Insights Into the Role of MicroRNA in Lung Cancer Resistance to Treatment and Targeted Therapy
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
241-258
Author(s):
Zhaohui Gong, Jie Yang, Jingqiu Li, Lihua Yang, Yanping Le, Shaomin Wang and Hui-Kuan Lin
Gene Delivery for Cancer Therapy
Journal:
Current Drug Delivery
Volume:
11
Page:
233-242
Author(s):
Teng Zhang
Inorganic Nanoparticles for In Vitro Cancer Diagnosis: A Patent Review
Journal:
Recent Patents on Nanomedicine
Volume:
3
Page:
89-98
Author(s):
Yan Zhang, Jing Ma, Shuang Dai, Yan Wang and Lei Wang
Association between MTHFR Gene Polymorphism and the Risk of Ovarian Cancer: A Meta-analysis of the Literature
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
1632-1638
Author(s):
Danhua Pu, Shi-Wen Jiang and Jie Wu
A Family of Pleiotropically Acting MicroRNAs in Cancer Progression, miR-200: Potential Cancer Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
1896-1903
Author(s):
Hai-Feng Zhang, Li-Yan Xu and En-Min Li
Histone Modifications, Stem Cells and Prostate Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
1687-1697
Author(s):
Francesco Crea, Pier-Luc Clermont, Antonello Mai and Cheryl D. Helgason